Antibody discovery at Antibody Engineering 2026

Dec 13–16, 2026 San Diego, CA ~900 attendees Website

64 organizations at Antibody Engineering 2026 present work in antibody discovery: 51 suppliers and service providers, 10 academic, government and non-profit bodies and 3 drug developers. Between them they bring 48 presentations to the program. Most represented: Genentech (3 on the program), University of Southampton (3 on the program), Alloy Therapeutics (2 on the program). 53 of them have their own page in this guide. As of Sep 26, 2026.

All 153 organizations at Antibody Engineering 2026 →

Showing 1–13 of 64 organizations

Organization	Antibody Engineering 2026 Attendance
Genentech South San Francisco, CA
gene.com Large pharma Biotechnology company and Roche Group member that discovers, develops and markets antibody and other medicines.	Talk Sun Dec 13 11:00am–11:45am Career Path/Experiences Panel Discussion Early Career Scientist Session · with Macaw Therapeutics, AstraZeneca Talk Mon Dec 14 2:30pm–3:00pm Dissecting the Mechanisms of Action of PROTABs: Insights into Designing Antibody-Based Protein Degraders How the shape of antibody binding decides whether a target protein on the cell surface is actually destroyed. Bispecifics & multispecifics Talk Tue Dec 15 8:10am–8:15am Co-Chairs’ Remarks Track 1: Advanced In Vivo Approaches to Antibody Discovery · with Johnson & Johnson Talk Tue Dec 15 8:15am–8:45am From COVID to Cancer: LNP-mRNA as an Antigen Format for Antibody Discovery Against Challenging Membrane Proteins Immunizing animals with mRNA packaged in tiny fat particles, so their antibodies recognize proteins embedded in cell membranes. Protein engineering
University of Southampton Southampton, United Kingdom
southampton.ac.uk Academic Public research university whose Centre for Cancer Immunology works on antibody immunotherapy and Fc receptor biology.	Talk Mon Dec 14 2:25pm–2:30pm Co-Chairs’ Remarks Track 2: Engineering Solutions for Accessing Difficult Targets · with Macaw Therapeutics Talk Mon Dec 14 4:45pm–5:15pm Disulfide Engineering of Immunostimulatory Antibodies for Augmented Receptor Agonism and Immune Cell Stimulation Adding chemical bridges between an antibody's two arms to lock its shape and make it switch on immune cells more strongly. Protein engineering Talk Tue Dec 15 8:10am–8:15am Co-Chairs' Remarks Track 2: Antibody Engineering for Proximity-Based Approaches · with Chai Discovery
Alloy Therapeutics Waltham, MA
alloytx.com Discovery platformsGold sponsor Provides ATX transgenic mice, display libraries and discovery services for antibodies and other drug modalities to drug developers.	Booth Exhibiting at Booth 220 Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Mon Dec 14 1:45pm–2:15pm Alloy Therapeutics Scientific Briefing Scientific Briefing 4 Antibody discovery Talk Wed Dec 16 7:30am–8:00am VHH and VLL Discovery Using ATX Transgenic Animals and Yeast Displayed Libraries Finding tiny single-piece human antibodies, using engineered mice and yeast-grown libraries, that can reach hidden pockets on a target. Antibody discovery
Harvard University Cambridge, MA
harvard.edu Academic Private research university, including Harvard Medical School.	Talk Mon Dec 14 2:30pm–3:00pm Discovery of G protein-coupled Receptor Modulator Antibody Fragments Small antibody fragments that switch on or block the large family of signal-receiving proteins in cell membranes. Protein engineering Talk Wed Dec 16 8:15am–8:45am A New Homotypic Interface Expands Anti-Malarial Antibody Recognition Breadth Evolving a malaria antibody so copies of it grip each other in a new way and protect against more parasite strains. Beyond oncology
Johnson & Johnson New Brunswick, NJ
jnj.com Large pharma Healthcare company whose Innovative Medicine segment develops antibodies, bispecifics and other medicines.	Talk Sun Dec 13 2:15pm–2:45pm Format Matters: Biophysical Characterization and Developability of Complex Biotherapeutics How a molecule's overall shape changes whether it can be made into a drug, across many measured antibody formats. Talk Tue Dec 15 8:10am–8:15am Co-Chairs’ Remarks Track 1: Advanced In Vivo Approaches to Antibody Discovery · with Genentech
University of Texas at Austin Austin, TX
utexas.edu Academic Public research university in Austin, Texas.	Talk Mon Dec 14 5:15pm–5:45pm Computational Approaches for Antibody and TCR Modeling Design and Discovery Track 1: Emerging In Vitro Approaches to Antibody Discovery AI & computational design Talk Tue Dec 15 10:30am–11:00am Utilizing Repertoire Mining to Complement In Vivo Antibody Discovery for Antibody Therapeutics Track 1: Advanced In Vivo Approaches to Antibody Discovery
Nona Biosciences
nonabio.com Discovery platformsBronze sponsor Fully human antibody discovery built on its Harbour Mice transgenic platforms for conventional and heavy-chain-only antibodies, offered as integrated discovery services.	Booth Exhibiting at Booth 105 Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Mon Dec 14 1:45pm–2:15pm Nona Bio Scientific Briefing Sponsored session · Scientific Briefing 2 Antibody discovery Talk Tue Dec 15 11:30am–12:00pm HCAb Harbour Mice® and AI for Next-Generation Therapeutic Antibody Discovery Mice that make human antibodies built from heavy chains alone, screened with computer models to find drug candidates. AI & computational design
Twist Bioscience South San Francisco, CA
twistbioscience.com Reagents & consumablesEvent partner Synthetic DNA company whose biopharma unit provides antibody libraries and antibody discovery and optimization services.	Booth Exhibiting at Booth 201 Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Mon Dec 14 12:15pm–1:15pm Engineering for Better Bispecifics: Introducing the B-Body® Platform A two-target antibody design meant to assemble reliably, avoiding low yields and hard purification when production scales up. Bispecifics & multispecificsDevelopability & CMC Talk Wed Dec 16 7:30am–8:00am A High-Throughput Ecosystem to Power AI-Driven Antibody Discovery Building large custom variant libraries so computer-designed antibodies can be made and tested in the lab within weeks. Antibody discoveryAI & computational design
GeneFrontier Kashiwa, Japan
genefrontier.com Reagents & consumablesBronze sponsor Sells PUREfrex cell-free protein synthesis reagents and applies them to antibody discovery and screening.	Booth Exhibiting (no floor booth listed) Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Tue Dec 15 12:35pm–1:05pm Cell Free Antibody Engineering: Accelerating Discovery and Screening with PUREfrex® Making antibody fragments and whole antibodies without living cells, then screening very diverse libraries from the same system. Antibody discovery
Invenra Madison, WI
invenra.com Discovery platformsSilver sponsor Antibody discovery company offering its B-Body bispecific and T-Body trispecific platforms to partners, including for multispecific antibody-drug conjugates.	Booth Exhibiting at Booth 108 Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Mon Dec 14 12:15pm–1:15pm From Bi- to Trispecific Antibodies: Reimagining the Next Generation of ADCs Antibodies that carry a cell-killing drug and bind several tumor targets, so tumors cannot escape by losing just one. ADCs & conjugatesBispecifics & multispecifics
Kactus Shanghai, China
kactusbio.com Reagents & consumablesBronze sponsor Makes recombinant proteins and enzymes, including membrane protein targets, for therapeutic antibody discovery.	Booth Exhibiting (no floor booth listed) Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Mon Dec 14 1:45pm–2:15pm From Native Membrane Proteins to Complex Therapeutic Targets: Enabling Next-Generation Antibody Discovery Displaying membrane proteins in virus-like particles or lipid discs, in their natural shape, so antibodies can be raised against them. Antibody discoveryProtein engineering
Nuclera Cambridge, United Kingdom
nuclera.com Instruments & analyticsSilver sponsor Makes the eProtein Discovery benchtop system, combining digital microfluidics and cell-free protein synthesis for rapid protein expression and screening.	Booth Exhibiting (no floor booth listed) Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Tue Dec 15 12:05pm–12:35pm The Missing Triage Step: Cell-Free Screening for Rapid, Low-Cost Antibody Hit Validation Making candidate antibodies without cells as a fast first filter, so only worthwhile ones go on to slower production. Antibody discovery
Primrose Bio San Diego, CA
primrosebio.com CRO & CDMOSilver sponsor Licenses its Pseudomonas-based Pfenex expression technology and provides strain engineering to take protein therapeutics from sequence to a GMP-ready process.	Booth Exhibiting at Booth 305 Mon, Dec 144:00pm–4:45pmTue, Dec 159:45am–4:45pm Talk Tue Dec 15 12:05pm–12:35pm From Hit Selection to Functional Testing: Reducing Expression Bottlenecks in Antibody Discovery Producing antibody fragments earlier in a different host organism, so more hits can actually be purified and tested. Antibody discoveryDevelopability & CMC